Global  

Covid 19 coronavirus AstraZeneca vaccine: Volunteer dies during human trials

New Zealand Herald Thursday, 22 October 2020
Covid 19 coronavirus AstraZeneca vaccine: Volunteer dies during human trialsA volunteer taking part in the trial for AstraZeneca's Covid-19 vaccine, which Australians could be given doses of, has died. A volunteer taking part in human trials for the University of Oxford's Covid-19 vaccine has died, sparking...
0
shares
ShareTweetSavePostSend
 
Video Credit: Reuters Studio - Published
News video: Brazilian dies in COVID-19 vaccine trial

Brazilian dies in COVID-19 vaccine trial 01:27

A volunteer who was taking part in clinical trials of the AstraZeneca vaccine in Brazil has died. The Brazilian health authority has confirmed that the trial will continue. Flora Bradley-Watson reports.

You Might Like


💡 One News Page Knowledge: Other News Mentions

AstraZeneca British-Swedish pharmaceutical company

Government could face ‘tough choices’ over vaccines [Video]

Government could face ‘tough choices’ over vaccines

The Government could face some “tough choices” if the vaccine produced byAstraZeneca and Oxford University is found to be less effective than others, aformer Department of Health director of immunisation has said. Professor DavidSalisbury said ministers would need to think “very carefully” about theirhandling of the vaccine if its efficacy was lower than for other jabs such asthose from Pfizer/BioNTech and Moderna. The AstraZeneca/Oxford vaccine iscurrently being assessed by the Medicines and Healthcare products RegulatoryAgency (MHRA) for use in the UK.Data from two arms of its phase-three trial,announced last week, gave a combined efficacy of 70%.

Credit: PA - Press Association STUDIO    Duration: 00:59Published
Astrazeneca Covid-19 vaccine: Company to run new tests amid fresh doubts [Video]

Astrazeneca Covid-19 vaccine: Company to run new tests amid fresh doubts

Credit: FRANCE 24 English    Duration: 01:33Published
Questions over AstraZeneca's COVID-19 vaccine data [Video]

Questions over AstraZeneca's COVID-19 vaccine data

British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a full dosage, a spokesman for the company said on Thursday, after its chief executive was quoted as saying an additional global trial was likely. This report produced by Jillian Kitchener.

Credit: Reuters - Politics    Duration: 01:29Published
AstraZeneca Admits COVID Breakthrough Came From Mistake [Video]

AstraZeneca Admits COVID Breakthrough Came From Mistake

AstraZeneca and the University of Oxford are facing criticism over their COVID-19 vaccine trial results. According to Business Insider the criticism comes after AstraZeneca admitted to a mistake in the vaccine dosage. During the vaccine trial, some patients got two full doses of the vaccine. Others had a half-dose in their first shot, followed by a full dose. On Wednesday, an AstraZeneca executive described the "mistake" as "serendipity.

Credit: Wochit News    Duration: 00:36Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Mass testing begins in bid to get students home for Christmas [Video]

Mass testing begins in bid to get students home for Christmas

Mass testing for Covid-19 is being rolled out at university campuses acrossthe UK in a bid to get students home with their families in time forChristmas.

Credit: PA - Press Association STUDIO    Duration: 01:26Published
Nitin Gadkari on infra projects, MSMEs & govt’s EV plan l #HTLS2020 [Video]

Nitin Gadkari on infra projects, MSMEs & govt’s EV plan l #HTLS2020

Union Minister Nitin Gadkari spoke at the 18th edition of the Hindustan Times Leadership Summit 2020 on infrastructure projects, the current state of MSMEs, the Covid challenge and the way ahead for the country. Gadkari said that while initially there was some hiccup, at present there is no impact of Covid on construction activities across the country. Gadkari also spoke on his government’s ambitions in the field of electric mobility. The Union Minister also recounted his journey of recovering from Covid and urged people to follow all preventive measures. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 36:22Published
Men's Mental Health Awareness Month: How to support their wellbeing [Video]

Men's Mental Health Awareness Month: How to support their wellbeing

In the age of Covid-19, the second lockdown is placing extreme stress on men of all ages and suicidal thoughts are soaring in the U.K., according to a study by The British Medical Journal.

Credit: Cover Video STUDIO    Duration: 01:26Published

Australians Australians

'It's heartbreaking': Australians stranded overseas unload on government's charter flight plans

Hotel quarantine limits have been cited as the key reason more Aussies haven't returned home, with an inquiry told of expensive, failed attempts to fly back.
SBS

Dangers of Iran's hostage diplomacy under the spotlight after shock release of Kylie Moore-Gilbert

Australians are being warned about travelling to Iran amid concerns they could be used as hostages for prisoner swap deals.
SBS

Stranded Australians furious at government

Labor will pressure Scott Morrison on his commitment to bring Australians stranded overseas home as the list of people keen to return grows.
SBS

Stranded Australians face race to return

Labor will pressure Scott Morrison on his commitment to bring Australians stranded overseas home as the list of people keen to return grows.
SBS

'There's a lot of fear': At least 50 Australians are stranded in northern Ethiopia amid an escalating conflict

The Australian government is facing growing calls to evacuate citizens and help negotiate an end to the conflict, with fears further escalation is imminent.
SBS

University of Oxford University of Oxford Collegiate research university in Oxford, England

Dosing Mix-up Raises Questions About New COVID Vaccine [Video]

Dosing Mix-up Raises Questions About New COVID Vaccine

A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed. The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford. Less than a week after we learned about it, the developers have admitted to a manufacturing error. The error resulted from two different doses during the recently concluded phase III trial. AstraZeneca and the University of Oxford described the vaccine as being 70% effective.

Credit: Wochit News    Duration: 00:39Published

Expert sees "nothing sinister" amid questions over vaccine's data

AstraZeneca and Oxford University acknowledged a manufacturing error that raised questions about preliminary results of their experimental COVID-19 vaccine.
CBS News

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute

Vaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian..
IndiaTimes

Related videos from verified sources

'Retire or quit': Nitin Gadkari on publicly reprimanding officials #HTLS2020 [Video]

'Retire or quit': Nitin Gadkari on publicly reprimanding officials #HTLS2020

Union minister Nitin Gadkari clarified on his recent viral speech in which he publicly reprimanded non-performing officials. At the 18th edition of the Hindustan Times Leadership Summit, the minister..

Credit: HT Digital Content     Duration: 04:16Published
OSHA: companies can legally impose vaccine requirements [Video]

OSHA: companies can legally impose vaccine requirements

As we get closer and closer to a COVID-19 vaccine, employers are now weighing whether they should make it mandatory for their staff. According to OSHA, companies can legally impose a vaccine..

Credit: KTNV Channel 13 Las Vegas     Duration: 00:29Published
Covid-19: ‘Can vaccinate everyone in Delhi within weeks’, says Satyendar Jain [Video]

Covid-19: ‘Can vaccinate everyone in Delhi within weeks’, says Satyendar Jain

Health Minister Satyendar Jain on Friday said Delhi has sufficient infrastructure and equipment to vaccinate its entire population in a few weeks once a COVID-19 vaccine is available."There is no need..

Credit: HT Digital Content     Duration: 03:15Published

Related news from verified sources

Covid 19 coronavirus AstraZeneca vaccine: Volunteer dies during human trials

Covid 19 coronavirus AstraZeneca vaccine: Volunteer dies during human trials
A volunteer taking part in the trial for AstraZeneca's Covid-19 vaccine, which Australians could be given doses of, has died. A volunteer taking part in human...
New Zealand Herald Also reported by •NaturalNews.comJapan TodayHinduRTTNews

'Oxford vaccine could be rolled out in 6 months'

The vaccine candidate under trial by University of Oxford scientists in collaboration with AstraZeneca is the furthest in the process of trials and, according to...
IndiaTimes Also reported by •WorldNewsNews24

AstraZeneca, Oxford University buoyed by vaccine response

British pharma giant AstraZeneca said on Monday trials of its coronavirus vaccine pioneered with Oxford University had shown "encouraging" responses among...
Japan Today Also reported by •SBSHinduUpworthyRTTNews